The Food and Drug Administration on Thursday posted a notification to healthcare professionals and patients that the agency continues to receive reports of methemoglobinemia, a serious and potentially fatal adverse effect, associated with benzocaine products, which are available as a spray, gel and liquids sold over the counter.
The National Advertising Division of the Council of Better Business Bureaus on Wednesday recommended that DSE Healthcare Solutions, which markets both Cystex urinary pain relief tablets and Cystex liquid cranberry complex with Proantinox, modify its advertising to better distinguish the two products.
Texas policymakers seeking to contain Medicaid costs should utilize community pharmacists to achieve both savings and optimal health outcomes, the National Community Pharmacists Association suggested on Thursday.
Illinois Circuit Judge John Belz on Tuesday ruled that Illinois pharmacists could refuse to dispense the emergency contraceptive Plan B, despite a 2005 edict that required pharmacists to dispense Plan B, regardless of their religious beliefs, according to published reports.
British drug maker Shire has filed suit against Watson Pharmaceuticals and subsidiaries, alleging patent infringement in a case concerning a drug used to treat attention deficit hyperactivity disorder.
Breast cancer survivors who experience large weight gain have an increased risk of death after diagnosis, according to research released Tuesday by scientists at the Kaiser Permanente Division of Research in Oakland, Calif.
An overwhelming majority of Consumer Reports readers are highly satisfied with their independent pharmacy experiences, as compared with experiences at some of the national chains, a report to be published in the May issue found.
Nature’s Gate is expanding its portfolio in May to include the new Herbal Blend hand creams, the first hand products from the personal care brand and the latest additions to the Herbal Blend collection.
Studies have indicated that proton-pump inhibitors, used for treating gastroesophageal reflux disease, reduce the efficacy of a popular blood-thinning drug, but Takeda Pharmaceuticals North America announced on Tuesday the results of a new study indicating that its own PPIs may have less of an effect.